The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently gave positive opinions on Novartis ‘ ( NVS ) Bexsero and Exjade (deferasirox).
Originally posted here:
CHMP Positive on Novartis Drugs – Analyst Blog